Oncode Accelerator ads

𝗪𝗵𝗮𝘁 𝗮𝗿𝗲 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿𝘀 𝗟𝗼𝗼𝗸𝗶𝗻𝗴 𝗳𝗼𝗿 𝗶𝗻 𝗧𝗿𝗮𝗻𝘀𝗹𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆? At the Oncode Accelerator Summit on December 3rd, Alexander Turkin (Business Developer & Head of New Ventures at Oncode Institute) and Cheryl Zimberlin (Managing Partner at Ligase BioPartners) will answer this question. Join them and other experts at our Summit to learn about technologies and innovations offered through our oncology ecosystem, see new results from Demonstrator Projects, and take part in discussions on how we can collaboratively 𝗣𝗼𝘄𝗲𝗿 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗣𝗿𝗼𝗴𝗿𝗲𝘀𝘀.

In 2025, Cumulus Oncology kick-started a Demonstrator Project with Oncode Accelerator. At this year’s Oncode Accelerator Summit, Tilly Bingham, CSO (GPCR Portfolio) at Cumulus Oncology, will give us an update in her presentation: 𝙄𝙣𝙩𝙚𝙧𝙫𝙚𝙣𝙞𝙣𝙜 𝙞𝙣 𝘾𝙤𝙡𝙤𝙧𝙚𝙘𝙩𝙖𝙡 𝘾𝙖𝙣𝙘𝙚𝙧 𝙬𝙞𝙩𝙝 𝙖 𝙉𝙤𝙫𝙚𝙡 𝙂𝙋𝙍𝟲𝟴-𝙏𝙖𝙧𝙜𝙚𝙩𝙚𝙙 𝙎𝙢𝙖𝙡𝙡 𝙈𝙤𝙡𝙚𝙘𝙪𝙡𝙚 Join Tilly and other experts on December 3rd to learn about technologies and innovations offered through our oncology ecosystem, see new results from Demonstrator Projects, and take part in discussions on how we can collaboratively 𝗣𝗼𝘄𝗲𝗿 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗣𝗿𝗼𝗴𝗿𝗲𝘀𝘀.

𝗛𝗼𝘄 𝗪𝗲 𝗖𝗮𝗻 𝗠𝗮𝗸𝗲 𝘁𝗵𝗲 𝗗𝘂𝘁𝗰𝗵 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺 𝗮 𝗦𝘂𝗰𝗰𝗲𝘀𝘀? We are thrilled to announce that Sanne Weijzen, Head of Cell Therapy Business and Portfolio Strategy at AstraZeneca, will share her perspective in a keynote speech at the 2026 Oncode Accelerator Summit. Join her and other experts on December 3rd to learn about technologies and innovations offered through our oncology ecosystem, see new results from Demonstrator Projects, and take part in discussions on how we can collaboratively 𝗣𝗼𝘄𝗲𝗿 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗣𝗿𝗼𝗴𝗿𝗲𝘀𝘀.

What is the value of 𝗡𝗲𝘄 𝗔𝗽𝗽𝗿𝗼𝗮𝗰𝗵 𝗠𝗲𝘁𝗵𝗼𝗱𝗼𝗹𝗼𝗴𝗶𝗲𝘀 𝗶𝗻 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆? In a parallel session at the Oncode Accelerator Summit, three experts will answer this question: ⭐ Marlous Kooijman, Program Manager Regulatory Innovation at Oncode Accelerator ⭐ Henriëtte Lanz, Vice President Biology at MIMETAS ⭐ Prof. Jeanine Roodhart, UMC Utrecht, Platform Lead Patient Cohorts at Oncode Accelerator Join them and other experts on December 3rd to learn about technologies and innovations offered through our oncology ecosystem, see new results from Demonstrator Projects, and take part in discussions on how we can collaboratively 𝗣𝗼𝘄𝗲𝗿 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗣𝗿𝗼𝗴𝗿𝗲𝘀𝘀.

𝙍𝙚𝙖𝙡-𝙒𝙤𝙧𝙡𝙙 𝙋𝙖𝙩𝙞𝙚𝙣𝙩 𝘿𝙖𝙩𝙖 𝙛𝙤𝙧 𝙋𝙧𝙚𝙘𝙡𝙞𝙣𝙞𝙘𝙖𝙡 𝘿𝙚𝙫𝙚𝙡𝙤𝙥𝙢𝙚𝙣𝙩: 𝙒𝙝𝙖𝙩, 𝙃𝙤𝙬 𝙖𝙣𝙙 𝙃𝙤𝙬 𝙈𝙪𝙘𝙝 𝙒𝙚 𝙉𝙚𝙚𝙙 𝙩𝙤 𝘾𝙤𝙡𝙡𝙚𝙘𝙩? This is a question that Professor Jürgen Kuball (UMC Utrecht) will answer in his presentation at the upcoming Oncode Accelerator Summit! Don’t miss the chance to join him and other experts at our Summit, to learn about technologies and innovations offered through our oncology ecosystem, see new results from Demonstrator Projects, and take part in discussions on how we can collaboratively 𝗣𝗼𝘄𝗲𝗿 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗣𝗿𝗼𝗴𝗿𝗲𝘀𝘀.

Join us at the 2026 Oncode Accelerator Summit, where we will explore how our R&D ecosystem is 𝗣𝗼𝘄𝗲𝗿𝗶𝗻𝗴 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗣𝗿𝗼𝗴𝗿𝗲𝘀𝘀. Expert speakers will explain their innovations within our oncology ecosystem, share insights from their Demonstrator Projects, and guide you through discussions on how we can collaboratively tackle the increasing burden of cancer on our society. Join us to hear from: ⭐ Louis Boon, CSO and Board Member at JJP Biologics ⭐ Sjoerd van der Burg, Professor of Cancer Immunology and Therapy at Leiden University Medical Center, Oncode Institute ⭐ Joel Rüegger, CEO of Omivera ⭐ Tilly Bingham, Executive in Residence at Cumulus Oncology ⭐ Jurjen Versluis, Internist-Hematologist at Erasmus MC ⭐ Jürgen Kuball, Professor and Chair of the Department of Hematology at UMC Utrecht ⭐ Cheryl Zimberlin, Managing Partner at Ligase BioPartners … And more! Will we see you there?